Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens.

Penaloza MacMaster P, Shields JL, Alayo QA, Cabral C, Jimenez J, Mondesir J, Chandrashekar A, Cabral JM, Lim M, Iampietro MJ, Provine NM, Bricault CA, Seaman M, Orlinger K, Aspoeck A, Fuhrmann G, Lilja AE, Monath T, Mangeat B, Pinschewer DD, Barouch DH.

Vaccine. 2017 Jan 3;35(1):1-9. doi: 10.1016/j.vaccine.2016.11.063. Epub 2016 Nov 26.

2.

Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector.

Schleiss MR, Berka U, Watson E, Aistleithner M, Kiefmann B, Mangeat B, Swanson EC, Gillis PA, Hernandez-Alvarado N, Fernández-Alarcón C, Zabeli JC, Pinschewer DD, Lilja AE, Schwendinger M, Guirakhoo F, Monath TP, Orlinger KK.

Clin Vaccine Immunol. 2017 Jan 5;24(1). pii: e00300-16. doi: 10.1128/CVI.00300-16. Print 2017 Jan.

3.

Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency.

Friedli M, Turelli P, Kapopoulou A, Rauwel B, Castro-Díaz N, Rowe HM, Ecco G, Unzu C, Planet E, Lombardo A, Mangeat B, Wildhaber BE, Naldini L, Trono D.

Genome Res. 2014 Aug;24(8):1251-9. doi: 10.1101/gr.172809.114. Epub 2014 May 30.

4.

Inhibition of HIV-1 replication by balsamin, a ribosome inactivating protein of Momordica balsamina.

Kaur I, Puri M, Ahmed Z, Blanchet FP, Mangeat B, Piguet V.

PLoS One. 2013 Sep 5;8(9):e73780. doi: 10.1371/journal.pone.0073780. eCollection 2013.

5.

TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.

Blanchet FP, Stalder R, Czubala M, Lehmann M, Rio L, Mangeat B, Piguet V.

Retrovirology. 2013 Jan 11;10:6. doi: 10.1186/1742-4690-10-6.

6.

Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, Kaiser L, Piguet V.

J Biol Chem. 2012 Jun 22;287(26):22015-29. doi: 10.1074/jbc.M111.319996. Epub 2012 Apr 6.

7.

Quantitative multicolor super-resolution microscopy reveals tetherin HIV-1 interaction.

Lehmann M, Rocha S, Mangeat B, Blanchet F, Uji-I H, Hofkens J, Piguet V.

PLoS Pathog. 2011 Dec;7(12):e1002456. doi: 10.1371/journal.ppat.1002456. Epub 2011 Dec 15.

8.

Arsenic modulates APOBEC3G-mediated restriction to HIV-1 infection in myeloid dendritic cells.

Stalder R, Blanchet F, Mangeat B, Piguet V.

J Leukoc Biol. 2010 Dec;88(6):1251-8. doi: 10.1189/jlb.0310176. Epub 2010 Aug 31.

PMID:
20807705
9.

Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition.

Bulliard Y, Turelli P, Röhrig UF, Zoete V, Mangeat B, Michielin O, Trono D.

J Virol. 2009 Dec;83(23):12611-21. doi: 10.1128/JVI.01491-09. Epub 2009 Sep 23.

10.

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation.

Mangeat B, Gers-Huber G, Lehmann M, Zufferey M, Luban J, Piguet V.

PLoS Pathog. 2009 Sep;5(9):e1000574. doi: 10.1371/journal.ppat.1000574. Epub 2009 Sep 4.

11.

Characterization of APOBEC3G binding to 7SL RNA.

Bach D, Peddi S, Mangeat B, Lakkaraju A, Strub K, Trono D.

Retrovirology. 2008 Jul 2;5:54. doi: 10.1186/1742-4690-5-54.

12.

APOBEC3-independent interferon-induced viral clearance in hepatitis B virus transgenic mice.

Turelli P, Liagre-Quazzola A, Mangeat B, Verp S, Jost S, Trono D.

J Virol. 2008 Jul;82(13):6585-90. doi: 10.1128/JVI.00216-08. Epub 2008 Apr 23.

13.

Identification of an arsenic-sensitive block to primate lentiviral infection of human dendritic cells.

Pion M, Stalder R, Correa R, Mangeat B, Towers GJ, Piguet V.

J Virol. 2007 Nov;81(21):12086-90. Epub 2007 Aug 29.

14.

Induction of antiviral cytidine deaminases does not explain the inhibition of hepatitis B virus replication by interferons.

Jost S, Turelli P, Mangeat B, Protzer U, Trono D.

J Virol. 2007 Oct;81(19):10588-96. Epub 2007 Jul 25.

15.

Model structure of human APOBEC3G.

Zhang KL, Mangeat B, Ortiz M, Zoete V, Trono D, Telenti A, Michielin O.

PLoS One. 2007 Apr 18;2(4):e378.

16.

Molecular mechanism of hepcidin deficiency in a patient with juvenile hemochromatosis.

Rideau A, Mangeat B, Matthes T, Trono D, Beris P.

Haematologica. 2007 Jan;92(1):127-8.

17.

APOBEC3G/3F mediates intrinsic resistance of monocyte-derived dendritic cells to HIV-1 infection.

Pion M, Granelli-Piperno A, Mangeat B, Stalder R, Correa R, Steinman RM, Piguet V.

J Exp Med. 2006 Dec 25;203(13):2887-93. Epub 2006 Dec 4.

18.

Lentiviral vectors and antiretroviral intrinsic immunity.

Mangeat B, Trono D.

Hum Gene Ther. 2005 Aug;16(8):913-20. Review.

PMID:
16076249
19.

APOBEC3G genetic variants and their influence on the progression to AIDS.

An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, Alobwede I, Trono D, Vlahov D, Donfield S, Goedert JJ, Phair J, Buchbinder S, O'Brien SJ, Telenti A, Winkler CA.

J Virol. 2004 Oct;78(20):11070-6.

20.

Inhibition of hepatitis B virus replication by APOBEC3G.

Turelli P, Mangeat B, Jost S, Vianin S, Trono D.

Science. 2004 Mar 19;303(5665):1829. No abstract available.

21.

A single amino acid determinant governs the species-specific sensitivity of APOBEC3G to Vif action.

Mangeat B, Turelli P, Liao S, Trono D.

J Biol Chem. 2004 Apr 9;279(15):14481-3. Epub 2004 Feb 13.

22.

Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts.

Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D.

Nature. 2003 Jul 3;424(6944):99-103. Epub 2003 May 28.

PMID:
12808466
23.

Cytoplasmic recruitment of INI1 and PML on incoming HIV preintegration complexes: interference with early steps of viral replication.

Turelli P, Doucas V, Craig E, Mangeat B, Klages N, Evans R, Kalpana G, Trono D.

Mol Cell. 2001 Jun;7(6):1245-54.

Supplemental Content

Loading ...
Support Center